Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy
- PMID: 21704908
- DOI: 10.1016/j.wneu.2011.03.029
Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy
Similar articles
-
Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report.Hum Pathol. 2013 Feb;44(2):282-8. doi: 10.1016/j.humpath.2012.07.022. Epub 2012 Oct 9. Hum Pathol. 2013. PMID: 23058249
-
Molecularly targeted therapies for recurrent glioblastoma: current and future targets.Neurosurg Focus. 2014 Dec;37(6):E15. doi: 10.3171/2014.9.FOCUS14519. Neurosurg Focus. 2014. PMID: 25434384 Free PMC article. Review.
-
Clonal diversity in glioblastoma: is it clinically relevant?Future Oncol. 2015;11(12):1703-6. doi: 10.2217/fon.15.73. Future Oncol. 2015. PMID: 26075436
-
Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.Cancer Cell. 2011 Dec 13;20(6):810-7. doi: 10.1016/j.ccr.2011.11.005. Epub 2011 Dec 1. Cancer Cell. 2011. PMID: 22137795
-
[p16 tumor suppressor gene alteration in brain tumors].No To Shinkei. 1998 Jun;50(6):511-7. No To Shinkei. 1998. PMID: 9656246 Review. Japanese. No abstract available.
Cited by
-
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.J Neuroradiol. 2015 Jul;42(4):212-21. doi: 10.1016/j.neurad.2014.02.006. Epub 2014 Jul 2. J Neuroradiol. 2015. PMID: 24997477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical